跳至主要内容
临床试验/NCT07662915
NCT07662915尚未招募不适用

Efficacy and Safety of Melanocyte Keratinocyte Transplantation Procedure Plus 308-nm Excimer Laser in the Treatment of Non-Vitiligo Leukoderma

Al-Azhar University0 个研究点目标入组 22 人开始时间: 2026年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
22

研究概览

简要总结

This study aims to compare the efficacy and safety of Melanocyte Keratinocyte Transplantation Procedure (MKTP) combined with 308-nm excimer laser versus Jodhpur technique combined with 308-nm excimer laser in the treatment of stable non-vitiligo leukoderma. Twenty-two patients with stable depigmented lesions will be enrolled. In each patient, two comparable lesions will be treated using different techniques. Clinical outcomes including percentage of repigmentation, color match, time to onset of repigmentation, complications, and histological changes will be assessed during follow-up to determine the optimal surgical treatment approach for non-vitiligo leukoderma.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 to 60 years.
  • Clinically diagnosed stable non-vitiligo leukoderma.
  • Stable lesion(s) for at least 6 months with no progression.
  • Inadequate response to conventional medical therapy.
  • Presence of two comparable lesions
  • Willingness to participate and provide written informed consent.

排除标准

  • Vitiligo or suspected active vitiligo.
  • History of keloid or hypertrophic scar formation.
  • Active infection at donor or recipient sites.
  • Bleeding disorders or anticoagulant therapy that cannot be safely discontinued.
  • Pregnancy or lactation.
  • Immunosuppression or uncontrolled systemic disease.
  • Inability to comply with follow-up visits.
  • Unrealistic expectations regarding treatment outcome.

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamed Mahmoud Mohamed Mahmoud

MD researcher

Al-Azhar University

相似试验

NCMT Technique and Jodhpur Technique and Excimer... | 临床试验